Back to News
Market Impact: 0.45
Appeals Court to Rule Soon on Marijuana Rescheduling as Billions in Cannabis Tax Benefits Hang in the Balance
Source: Newswire
Regulation & LegislationTax & TariffsLegal & LitigationHealthcare & Biotech
The D.C. Circuit is preparing to rule on whether the Justice Department lawfully reclassified marijuana under DEA Schedule 3, placing billions of dollars in anticipated cannabis-industry tax relief at risk. An adverse ruling could unwind the expected reduction in punitive federal tax treatment for state-legal marijuana businesses and pressure sector valuations.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.35
More News
- Looters hit 3,000 French businesses. Within hours, the haul was trending on Vinted under the riot’s date
- Vertex reports positive IgAN trial data, FDA decision due Nov. 30
- The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.
- With earnings in rearview mirror, SpaceX-Tesla merger chatter takes center stage
- J&J prostate cancer drug shows promising tumor responses in early trial
- Piero Cipollone: Interview with Milano Finanza
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AI in Asset Management: 2026 Statistics That Hold Up
- What is Broker Research and RMS Systems (And How to Actually Use Them)